Answer
Cabotegravir is primarily metabolised by UGT1A1, with a minor contribution from UGT1A9.
Sources for this answer
- Vocabria 600 mg prolonged-release suspension for injectionViiV Healthcare UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 11Document updated
Sources checked